Insider · CIK 0001816196

Detheux Michel

Reports to the SEC for 2 companies · BOSTON, MA

sec.gov

Transactions

Companies

Filings

CIK

0001816196

Forms 4 and 5

Insider transactions

50 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-06-11	VORVor Biopharma Inc. · Stock option (right to buy)A Award	Director	AAward	+57.2K sh	—	—	57,162
2025-08-29	iTeos Therapeutics, Inc.Stock Option (Right to Buy)D Disposition to Issuer	Director, Chief Executive Officer	DDisposition to Issuer	−52.7K sh	—	—	0
2025-08-29	iTeos Therapeutics, Inc.U Disposition from Tender	Director, Chief Executive Officer	UDisposition from Tender	−154K sh	—	—	0
2025-08-29	iTeos Therapeutics, Inc.Stock Option (Right to Buy)D Disposition to Issuer	Director, Chief Executive Officer	DDisposition to Issuer	−50.1K sh	—	—	0
2025-08-29	iTeos Therapeutics, Inc.U Disposition from Tender	Director, Chief Executive Officer	UDisposition from Tender	−94K sh	—	—	0
2025-08-29	iTeos Therapeutics, Inc.Stock Option (Right to Buy)D Disposition to Issuer	Director, Chief Executive Officer	DDisposition to Issuer	−14.2K sh	—	—	0
2025-08-29	iTeos Therapeutics, Inc.Stock Option (Right to Buy)D Disposition to Issuer	Director, Chief Executive Officer	DDisposition to Issuer	−185K sh	—	—	0
2025-08-29	iTeos Therapeutics, Inc.Stock Option (Right to Buy)D Disposition to Issuer	Director, Chief Executive Officer	DDisposition to Issuer	−94.3K sh	—	—	0
2025-08-29	iTeos Therapeutics, Inc.Stock Option (Right to Buy)D Disposition to Issuer	Director, Chief Executive Officer	DDisposition to Issuer	−17.5K sh	—	—	0
2025-08-29	iTeos Therapeutics, Inc.Stock Option (Right to Buy)D Disposition to Issuer	Director, Chief Executive Officer	DDisposition to Issuer	−445K sh	—	—	0
2025-07-16	VORVor Biopharma Inc. · Stock Option (right to buy)A Award	Director	AAward	+60K sh	—	—	60,000
2025-06-10	iTeos Therapeutics, Inc.M Exercise/Conversion	Director, Chief Executive Officer	MExercise/Conversion	+94K sh	$4.30	+$404K	94,027
2025-06-10	iTeos Therapeutics, Inc.M Exercise/Conversion	Director, Chief Executive Officer	MExercise/Conversion	+18K sh	$4.30	+$77.4K	153,903
2025-06-10	iTeos Therapeutics, Inc.S Sale	Director, Chief Executive Officer	SSale	−43.9K sh	$10.02	−$440K	0
2025-06-10	iTeos Therapeutics, Inc.S Sale	Director, Chief Executive Officer	SSale	−8,400 sh	$10.02	−$84.2K	135,903
2025-06-10	iTeos Therapeutics, Inc.Stock Option (Right to Buy)M Exercise/Conversion	Director, Chief Executive Officer	MExercise/Conversion	−8,400 sh	—	—	18,000
2025-06-10	iTeos Therapeutics, Inc.M Exercise/Conversion	Director, Chief Executive Officer	MExercise/Conversion	+43.9K sh	$4.30	+$189K	43,883
2025-06-10	iTeos Therapeutics, Inc.Stock Option (Right to Buy)M Exercise/Conversion	Director, Chief Executive Officer	MExercise/Conversion	−94K sh	—	—	3
2025-06-10	iTeos Therapeutics, Inc.Stock Option (Right to Buy)M Exercise/Conversion	Director, Chief Executive Officer	MExercise/Conversion	−43.9K sh	—	—	94,030
2025-06-10	iTeos Therapeutics, Inc.Stock Option (Right to Buy)M Exercise/Conversion	Director, Chief Executive Officer	MExercise/Conversion	−18K sh	—	—	0
2025-06-10	iTeos Therapeutics, Inc.M Exercise/Conversion	Director, Chief Executive Officer	MExercise/Conversion	+8,400 sh	$4.30	+$36.1K	144,303
2025-06-09	iTeos Therapeutics, Inc.Stock Option (Right to Buy)M Exercise/Conversion	Director, Chief Executive Officer	MExercise/Conversion	−8,400 sh	—	—	26,400
2025-06-09	iTeos Therapeutics, Inc.S Sale	Director, Chief Executive Officer	SSale	−43.9K sh	$10.03	−$440K	0
2025-06-09	iTeos Therapeutics, Inc.M Exercise/Conversion	Director, Chief Executive Officer	MExercise/Conversion	+43.9K sh	$4.30	+$189K	43,882
2025-06-09	iTeos Therapeutics, Inc.Stock Option (Right to Buy)M Exercise/Conversion	Director, Chief Executive Officer	MExercise/Conversion	−43.9K sh	—	—	137,913
2025-06-09	iTeos Therapeutics, Inc.S Sale	Director, Chief Executive Officer	SSale	−8,400 sh	$10.03	−$84.3K	135,903
2025-06-09	iTeos Therapeutics, Inc.M Exercise/Conversion	Director, Chief Executive Officer	MExercise/Conversion	+8,400 sh	$4.30	+$36.1K	144,303
2025-06-06	iTeos Therapeutics, Inc.S Sale	Director, Chief Executive Officer	SSale	−43.9K sh	$10.21	−$448K	0
2025-06-06	iTeos Therapeutics, Inc.S Sale	Director, Chief Executive Officer	SSale	−8,400 sh	$10.21	−$85.8K	135,903
2025-06-06	iTeos Therapeutics, Inc.Stock Option (Right to Buy)M Exercise/Conversion	Director, Chief Executive Officer	MExercise/Conversion	−8,400 sh	—	—	34,800
2025-06-06	iTeos Therapeutics, Inc.Stock Option (Right to Buy)M Exercise/Conversion	Director, Chief Executive Officer	MExercise/Conversion	−43.9K sh	—	—	181,795
2025-06-06	iTeos Therapeutics, Inc.M Exercise/Conversion	Director, Chief Executive Officer	MExercise/Conversion	+43.9K sh	$4.30	+$189K	43,882
2025-06-06	iTeos Therapeutics, Inc.M Exercise/Conversion	Director, Chief Executive Officer	MExercise/Conversion	+8,400 sh	$4.30	+$36.1K	144,303
2025-06-05	iTeos Therapeutics, Inc.M Exercise/Conversion	Director, Chief Executive Officer	MExercise/Conversion	+43.9K sh	$4.30	+$189K	43,882
2025-06-05	iTeos Therapeutics, Inc.Stock Option (Right to Buy)M Exercise/Conversion	Director, Chief Executive Officer	MExercise/Conversion	−8,400 sh	—	—	43,200
2025-06-05	iTeos Therapeutics, Inc.M Exercise/Conversion	Director, Chief Executive Officer	MExercise/Conversion	+8,400 sh	$4.30	+$36.1K	144,303
2025-06-05	iTeos Therapeutics, Inc.Stock Option (Right to Buy)M Exercise/Conversion	Director, Chief Executive Officer	MExercise/Conversion	−43.9K sh	—	—	225,677
2025-06-05	iTeos Therapeutics, Inc.S Sale	Director, Chief Executive Officer	SSale	−8,400 sh	$10.15	−$85.3K	135,903
2025-06-05	iTeos Therapeutics, Inc.S Sale	Director, Chief Executive Officer	SSale	−43.9K sh	$10.15	−$445K	0
2025-06-04	iTeos Therapeutics, Inc.S Sale	Director, Chief Executive Officer	SSale	−43.9K sh	$10.10	−$443K	0
2025-06-04	iTeos Therapeutics, Inc.M Exercise/Conversion	Director, Chief Executive Officer	MExercise/Conversion	+43.9K sh	$4.30	+$189K	43,883
2025-06-04	iTeos Therapeutics, Inc.Stock Option (Right to Buy)M Exercise/Conversion	Director, Chief Executive Officer	MExercise/Conversion	−43.9K sh	—	—	269,559
2025-06-04	iTeos Therapeutics, Inc.Stock Option (Right to Buy)M Exercise/Conversion	Director, Chief Executive Officer	MExercise/Conversion	−8,400 sh	—	—	51,600
2025-06-04	iTeos Therapeutics, Inc.S Sale	Director, Chief Executive Officer	SSale	−8,400 sh	$10.10	−$84.8K	135,903
2025-06-04	iTeos Therapeutics, Inc.M Exercise/Conversion	Director, Chief Executive Officer	MExercise/Conversion	+8,400 sh	$4.30	+$36.1K	144,303
2025-03-07	iTeos Therapeutics, Inc.A Award	Director, Chief Executive Officer	AAward	+77K sh	—	—	135,903
2025-03-07	iTeos Therapeutics, Inc.Stock Option (Right to Buy)A Award	Director, Chief Executive Officer	AAward	+459K sh	—	—	459,000
2024-08-08	iTeos Therapeutics, Inc.Stock Option (Right to Buy)G Gift	Director, Chief Executive Officer	GGift	+443K sh	—	—	442,800
2024-08-08	iTeos Therapeutics, Inc.Stock Option (Right to Buy)G Gift	Director, Chief Executive Officer	GGift	−443K sh	—	—	147,600
2024-03-07	iTeos Therapeutics, Inc.Stock Option (Right to Buy)A Award	Director, Chief Executive Officer	AAward	+590K sh	—	—	590,400

Recent filings

Accepted (ET)
Jun 124
Detheux Michel0001193125-26-270002
SEC(opens sec.gov)
Aug 294
Detheux Michel0000950170-25-112240
SEC(opens sec.gov)
Jul 184
Detheux Michel0001415889-25-020024
SEC(opens sec.gov)
Jun 114
Detheux Michel0000950170-25-085047
SEC(opens sec.gov)

Companies

Address

500 BOYLSTON STREET, SUITE 1350

BOSTON, MA, 02116